Fig. 1From: Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized triala Comparison of 5-year DFS rate between MSD and AD; b 5-year OS rate between MSD and ADBack to article page